The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Excess mortality of schizophrenia: A meta-analysis
Abstract
BACKGROUND: This paper presents a structured review of the published information on the mortality of schizophrenia. METHOD: A meta-analysis of the literature. RESULTS: Schizophrenia has a significantly increased mortality from natural and unnatural causes. Twenty-eight percent of the excess mortality is attributable to suicide and 12% to accidents. The rest of the excess mortality is from the same broad range of conditions which cause deaths in the general population. Further interpretation is hampered by confounding variables, wide confidence intervals and reservations about generalising from individual cohorts. CONCLUSIONS: The available evidence suggests that schizophrenia is associated with a large increased mortality from suicide and a moderate increased mortality from natural causes. A number of possible interventions have been identified, but we do not yet have reliable means of detecting any changes in mortality which might result.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The SMR in persons with schizophrenia was found to be 1.51, i.e., the mortality rate was on average 51% higher than that of the general population.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Brown 1997
In the citing paper
“we noted period effects suggestive of a widening mortality gap, insofar as a greater relative all-cause mortality risk was observed for the decade of follow-up for this cohort than that reported for earlier de- cades.4,9,12,35,36”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [35]
Citations
Cites
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Measuring the Quality of Medical Care
Rutstein, D. D., Berenberg, W., Chalmers, T. C., Child, C. G., Fishman, A. P., Perrin, E. B., Feldman, J. J., Leaverton, P. E., Lane, J. M., Sencer, D. J., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197603112941104 · Cited by 1,004
Meta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 774
Prediction of Suicide in Psychiatric Patients
Pokorny, A. D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030019002 · Cited by 749
Schizophrenics Kill Themselves Too: A Review of Risk Factors for Suicide
Caldwell, C. B., & Gottesman, I. I. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.4.571 · Cited by 511
Meta-analysis: State-of-the-Science
Dickersin, K., & Berlin, J. A. (1992) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036084 · Cited by 495
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Graunt, J. (1977) · Biomathematics · doi:10.1007/978-3-642-81046-6_2 · Cited by 396
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 372
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Dupont, 1986, Psychiatric Case Registers in Public Health
- 1995, 1993 Mortality Statistics. Cause
Cited by
Sorted by citations
Items 301–400 of 869
Treatment of clozapine-associated weight gain: a systematic review
Whitney, Z., Procyshyn, R. M., Fredrikson, D. H., & Barr, A. M. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1807-1 · Cited by 42
The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging
Mathias, S., Knowles, E., Barrett, J., Leach, O. K., Buccheri, S., Beetham, T., Blangero, J., Poldrack, R., & Glahn, D. (2017) · Schizophrenia bulletin · doi:10.1093/schbul/sbw168 · Cited by 39
Desai, M. G., Tanus-Santos, J. E., Li, L., Gorski, J. C., Arefayene, M., Liu, Y., Desta, Z., & Flockhart, D. A. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500160 · Cited by 42
Sudden Death of Cardiac Origin and Psychotropic Drugs
Timour, Q., Frassati, D., Descotes, J., Chevalier, P., Christé, G., & Chahine, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00076 · Cited by 43
Mortality and tardive dyskinesia: long-term study using the US National Death Index
Dean, C. E., & THURAS, P. D. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.049395 · Cited by 42
Effects of olanzapine and clozapine upon pulse rate variability
Müeck‐Weymann, M., Rechlin, T., Ehrengut, F., Rauh, R., Acker, J. G., Dittmann, R., Czekalla, J., Joraschky, P., & Musselman, D. L. (2002) · Depression and Anxiety · doi:10.1002/da.10037 · Cited by 42
Brauer, R., Douglas, I., & Smeeth, L. L. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04043.x · Cited by 41
Calhoun, P. S., Bosworth, H. B., Stechuchak, K. A., Strauss, J., & Butterfield, M. I. (2006) · Journal of Traumatic Stress · doi:10.1002/jts.20114 · Cited by 41
The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation
Dietrich‐Muszalska, A., Rabe‐Jabłońska, J., Nowak, P., & Kontek, B. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802505792 · Cited by 40
Gaal, L. F. V. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.06.005 · Cited by 40
Kochunov, P., Chiappelli, J., Wright, S. N., Rowland, L. M., Patel, B., Wijtenburg, S. A., Nugent, K. L., McMahon, R. P., Carpenter, W. T., Muellerklein, F., et al. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.05.004 · Cited by 42
Sex Differences in Completed Suicide by Schizophrenic Patients: A Meta‐Analysis
Lester, D. (2006) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2006.36.1.50 · Cited by 40
Mortality among first-admission patients with psychosis
Craig, T., Ye, Q., & Bromet, E. J. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.11.004 · Cited by 40
Cardiovascular risk in individuals with depression
Bivanco-Lima, D., Santos, I. S., Vannucchi, A. M. C., & Ribeiro, M. C. S. D. A. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2012.12.006 · Cited by 41
Landén, M., Davidsson, P., Gottfries, C., Stridsberg, B. G., & Blennow, K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00160-2 · Cited by 40
Warner, B., Alphs, L. D., Schaedelin, J., & Koestler, T. P. (2000) · The Lancet · doi:10.1016/s0140-6736(05)72452-1 · Cited by 40
López-Moríñigo, J.-D., Forti, M. D., Ajnakina, O., Wiffen, B. D. R., Morgan, K. D., Doody, G. A., Jones, P. B., Ayesa‐Arriola, R., Canal‐Rivero, M., Crespo‐Facorro, B., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.016 · Cited by 42
Allostatic load and systemic comorbidities in psychiatric disorders
Finlay, S., Rudd, D., McDERMOTT, B. M., & Sarnyai, Z. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105726 · Cited by 44
Heart Disease, Schizophrenia, and Affective Psychoses: Epidemiology of Risk in Primary Care
McDermott, S. W., Moran, R., Platt, T., Isaac, T., Wood, H., & Dasari, S. (2005) · Community Mental Health Journal · doi:10.1007/s10597-005-6431-6 · Cited by 39
Basu, A., & Meltzer, H. Y. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.04.014 · Cited by 39
Hyperglycemia and Hypertriglyceridemia in Real World Patients on Antipsychotic Therapy
Gupta, S., Steinmeyer, C. H., Frank, B. L., Madhusoodanan, S., Lockwood, K., Lentz, B., & Keller, P. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200309000-00007 · Cited by 39
Kao, L. W., & Furbee, R. B. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2005.06.003 · Cited by 40
Psychiatric Aspects of Suicidal Behaviour: Schizophrenia
Binder, M. D., & Peuskens, J. (2000) · doi:10.1002/9780470698976.ch8 · Cited by 39
Suicidality prior to presentation in first‐episode psychosis
Foley, S. R., Jackson, D., McWilliams, S., Renwick, L., Sutton, M., Turner, N., Kinsella, A., & O’Callaghan, E. (2008) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00084.x · Cited by 38
Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection
Morrato, E. H., Cuffel, B. J., Newcomer, J. W., Lombardo, I., Kamat, S., & Barron, J. O. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819294cb · Cited by 38
Improving the Physical Health of Patients with Schizophrenia: Therapeutic Nihilism or Realism?
Fevre, P. D. L. (2001) · Scottish Medical Journal · doi:10.1177/003693300104600105 · Cited by 37
Elevated expression of integrin αIIb βIIIa in drug-naïve, first-episode schizophrenic patients
Walsh, M.-T. H., Ryan, M. C. M., Hillmann, A. G., Condren, R. M., Kenny, D. J., Dinan, T. G., & Thakore, J. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01400-2 · Cited by 38
Rao, J. S., Chiappelli, J., Kochunov, P. V., Regenold, W. T., Rapoport, S. I., & Hong, L. E. (2014) · Neurodegenerative Diseases · doi:10.1159/000369214 · Cited by 37
Characteristics of Suicide Attempts in Young People Undergoing Treatment for First Episode Psychosis
Fedyszyn, I. E., Harris, M., Robinson, J., Edwards, J., & Paxton, S. J. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595687 · Cited by 37
How do General Practitioners experience providing care for their psychotic patients?
Oud, M., Schuling, J., Slooff, C. J., & Jong, B. M. (2007) · BMC Family Practice · doi:10.1186/1471-2296-8-37 · Cited by 37
McGinty, E. E., Presskreischer, R., Breslau, J. A., Brown, J. D., Domino, M. E., Druss, B. G., Horvitz-Lennon, M. V., Murphy, K. A., Pincus, H. A., & Daumit, G. L. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000768 · Cited by 36
Health Behaviors and Health Status of Older Women With Schizophrenia
Dickerson, F., Pater, A., & Origoni, A. E. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.882 · Cited by 37
McGinty, E. E., Kennedy‐Hendricks, A., Linden, S., Pessar, S. C., Stone, E. M., & Daumit, G. L. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.12.003 · Cited by 36
Wootten, J. C., Wiener, J. C., Blanchette, P., & Anderson, K. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102233 · Cited by 36
Landén, M., Grenfeldt, B., Davidsson, P., Stridsberg, M., Regland, B., Gottfries, C., & Blennow, K. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00042-x · Cited by 36
Antipsychotics and Metabolics in the Post-CATIE Era
Meyer, J. M. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_45 · Cited by 36
Metabolic Adverse Events in Patients With Mental Illness Treated With Antipsychotics
Balf, G., Stewart, T. D., Whitehead, R. E., & Baker, R. A. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0104 · Cited by 36
Weiser, P., Becker, T. M., Losert, C., Alptekın, K., Berti, L., Burti, L., Burton, A., Dernovšek, M. Z., Dragomirecká, E., Freidl, M., et al. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-315 · Cited by 36
Pearsall, R., Hughes, S., Geddes, J. R., & Pelosi, A. J. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-38 · Cited by 34
Shah, P., Iwata, Y., Caravaggio, F., Plitman, E., Brown, E. E., Kim, J., Chan, N. K., Hahn, M., Remington, G. J., Gerretsen, P., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.005 · Cited by 35
Trajectories of suicidal ideation after first‐episode psychosis: a growth mixture modeling approach
Salagre, E., Grande, I., Jiménez, E., Mezquida, G., Cuesta, M. J., Llorente, C., Amoretti, S., Lobo, A., González-Pinto, A. M., Carballo, J. J., et al. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13279 · Cited by 35
Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization
Rantanen, H., Koivisto, A., Salokangas, R. K. R., Helminen, M., Oja, H., Pirkola, S. P., Wahlbeck, K., & Joukamaa, M. I. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0414-1 · Cited by 39
Serum lipid levels and suicidality among male patients with schizoaffective disorder
Marčinko, D., Marčinko, V. M., Karlović, D., Marčinko, A., Martinac, M., Begić, D., & Jakovljević, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.009 · Cited by 35
Ganesh, S., Ashok, A., Kumar, C., & Thirthalli, J. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.05.006 · Cited by 31
Co-morbid PTSD and suicidality in individuals with schizophrenia and substance and alcohol abuse
Tarrier, N., & Picken, A. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0277-0 · Cited by 33
Morgan, M. G., Scully, P. J., Youssef, H. A., Kinsella, A., Owens, J. M., & Waddington, J. L. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00002-7 · Cited by 34
Temmingh, H., Claassen, A., van Zyl, S., Carrara, H., Dayakalashe, N. M., Myer, L., & Stein, D. J. (2013) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000036 · Cited by 31
Sex differences in schizophrenia: A review
Sami Räsänen, A. P. (2000) · Nordic Journal of Psychiatry · doi:10.1080/080394800427564 · Cited by 32
Is there an evolutionary advantage of schizophrenia?
Nichols, C. (2009) · Personality and Individual Differences · doi:10.1016/j.paid.2009.01.013 · Cited by 32
Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series
Jönsson, A. K., Brudin, L. H., Ahlner, J., Hedenmalm, K., Eriksson, A., & Hägg, S. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282fe9d44 · Cited by 33
Yang, F., Wang, K., Du, X., Deng, H., Wu, H. E., Yin, G., Ning, Y., Huang, X., Teixeira, A. L., Quevedo, J., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5107-1 · Cited by 33
Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics
Kane, J. M., Conley, R. R., Keith, S. J., Nasrallah, H. A., & Turner, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0121 · Cited by 33
Temporal pattern of suicide risk in young individuals with early psychosis
Fedyszyn, I. E., Robinson, J., Matyas, T. A., Harris, M., & Paxton, S. J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.006 · Cited by 33
López-Moríñigo, J.-D., Ayesa‐Arriola, R., Torres-Romano, B., Fernandes, A. C., Shetty, H., Broadbent, M. T. M., Dominguez-Ballesteros, M.-E., Stewart, R. J., David, A. S., & Dutta, R. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011929 · Cited by 34
The toxicology and comorbidities of fatal cases involving quetiapine
Pilgrim, J. L., & Drummer, O. H. (2013) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-012-9404-4 · Cited by 32
Dangerous or merely ‘difficult’? The new population of forensic mental hospitals
Schanda, H., Stompe, T., & Ortwein-Swoboda, G. (2009) · European psychiatry · doi:10.1016/j.eurpsy.2009.07.006 · Cited by 32
Martín-Sierra, A., Vancampfort, D., Probst, M., Bobes, J., Maurissen, K., Sweers, K., Schepper, E. D., & Hert, M. D. (2011) · Actas Españolas de Psiquiatría · Cited by 31
Bouza, C., López‐Cuadrado, T., & Amate, J. M. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.11.014 · Cited by 32
Schizophrenia Into Later Life: Treatment, Research, and Policy
(2003) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377060 · Cited by 32
Prevalence and associations of the metabolic syndrome among patients prescribed clozapine
Ahmed, M. R., Hussain, I., O’Brien, S. M., Dineen, B., Griffin, D. G., & McDonald, C. (2008) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-008-0156-9 · Cited by 32
Miller, B. J., Kandhal, P. K., Rapaport, M. H., Mellor, A. L., & Buckley, P. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.12.005 · Cited by 31
Improving the physical health of long-term psychiatric inpatients
Hjorth, P., Davidsen, A., Kilian, R., Eriksen, S. P., Jensen, S. O. W., Sørensen, H. Ø., & Munk-Jørgensen, P. (2014) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1177/0004867414533011 · Cited by 31
Callaghan, R. C., Boire, M. D., Lazo, R. G., McKenzie, K. J., & Cohn, T. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.018 · Cited by 31
Outcome from a Community-based Smoking Cessation Program for Persons with Serious Mental Illness
Currie, S. R., Karltyn, J., Lussier, D., de Denus, E., Brown, D., & el‐Guebaly, N. (2007) · Community Mental Health Journal · doi:10.1007/s10597-007-9113-8 · Cited by 31
Quality and Predictors of Diabetes Care Among Patients With Schizophrenia: A Danish Nationwide Study
Jørgensen, M., Mainz, J., Carinci, F., Thomsen, R. W., & Johnsen, S. P. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600460 · Cited by 31
The General Health Status of People with Mental Illness
Davidson, S. K., Judd, F. K., Jolley, D., Hocking, B. M., & Thompson, S. (2000) · Australasian Psychiatry · doi:10.1046/j.1440-1665.2000.00234.x · Cited by 31
Predictors of suicide in Asian patients with first episode psychosis
Mitter, N., Subramaniam, M., Abdin, E., Poon, L. Y., & Verma, S. K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.006 · Cited by 30
Neurocognitive function in long-term treated schizophrenia: A five-year follow-up study
Ekerholm, M., Firus, S., Fagerberg, T., Söderman, E., Terenius, L. Y., Agartz, I., Jönsson, E. G., & Nyman, H. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.05.008 · Cited by 30
Pallava, A., Chadda, R. K., Sood, M., & Ramakrishnan, L. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.621977 · Cited by 30
Lin, H.-C., Chen, Y., Lee, H.-C., & Lin, H. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903487209 · Cited by 30
McIntyre, R. S., Cragin, L. S., Sorensen, S. V., Naci, H., Baker, T., & Roussy, J. (2010) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2009.01189.x · Cited by 30
Lykouras, L., & Douzenis, A. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32830079d0 · Cited by 32
Jackson, C. T., Covell, N. H., Drake, R. E., & Essock, S. M. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.2.270 · Cited by 30
Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder
Asoglu, M., Aslan, M., İmre, O., Kıvrak, Y., Akıl, Ö., Şavik, E., Büyükaslan, H., Fedai, Ü. A., & Altındağ, A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111108 · Cited by 29
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia
Yu, W., Binder, M. D., Moons, T., Claes, S. J., Correll, C. U., & van Winkel, R. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318283925e · Cited by 29
Regional Differences in Five-Year Mortality After a First Episode of Schizophrenia in Finland
Kiviniemi, M., Suvisaari, J., Pirkola, S. P., Häkkinen, U., Isohanni, M. K., & Hakko, H. H. (2010) · Psychiatric Services · doi:10.1176/ps.2010.61.3.272 · Cited by 32
Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK
Davies, A., Vardeva, K., Loze, J.-Y., L'Italien, G. J., Sennfält, K., & van Baardewijk, M. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802507547 · Cited by 29
Sertindole: efficacy and safety in schizophrenia
Lindström, E., & Levander, S. E. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.13.1825 · Cited by 29
Lee, S., Rothbard, A. B., & Choi, S. (2015) · Journal of Mental Health · doi:10.3109/09638237.2015.1101420 · Cited by 29
Risperidone in Schizophrenia: Is There a Role for Therapeutic Drug Monitoring?
Seto, K., Dumontet, J., & Ensom, M. H. H. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182126d83 · Cited by 29
Seow, E., Chong, S. A., Wang, P., Shafie, S., Ong, H. L., & Subramaniam, M. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.01.017 · Cited by 29
Care provided by general practitioners to patients with psychotic disorders: a cohort study
Oud, M., Schuling, J., Groenier, K. H., Verhaak, P. F. M., Slooff, C. J., Dekker, J. H., & Jong, B. M. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-92 · Cited by 26
Handbook of Schizophrenia Spectrum Disorders, Volume II
Ritsner, M. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0 · Cited by 28
Canal‐Rivero, M., Barrigón, M. L., Garcelán, S. P., Testal, J. F. R., Giner, L., Obiols, J. E., & Ruíz-Veguilla, M. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.08.014 · Cited by 28
McNamara, R. K., & Almeida, D. M. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000199 · Cited by 30
Kuo, M.-W., Yeh, S., Chang, H.-M., & Teng, P. (2020) · BMC Oral Health · doi:10.1186/s12903-020-01280-7 · Cited by 31
Associations between symptoms and all-cause mortality in individuals with serious mental illness
Hayes, R. D., Chang, C., Fernandes, A. C., Begum, A., To, D., Broadbent, M. T. M., Hotopf, M. H., & Stewart, R. J. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.09.012 · Cited by 28
Pfrimmer, D. M. (2009) · The Journal of Continuing Education in Nursing · doi:10.3928/00220124-20090201-04 · Cited by 29
Modelling disease frequency measures in schizophrenia epidemiology
Saha, S., Barendregt, J. J., Vos, T., Whiteford, H., & McGrath, J. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.05.022 · Cited by 28
Cardiovascular disease and diabetes in people with severe mental illness
Binder, M. D., Dekker, J. M., Wood, D. A., Kahl, K. G., & Möller, H. (2009) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(09)70031-7 · Cited by 27
Detection of Metabolic Syndrome in Schizophrenia and Implications for Antipsychotic Therapy
Burghardt, K. J., & Ellingrod, V. L. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0017-8 · Cited by 27
Panariello, F., Perruolo, G., Cassese, A., Giacco, F., Botta, G., Barbagallo, A., Muscettola, G., Bèguinot, F., Formisano, P., & de Bartolomeis, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22864 · Cited by 27
Vera‐Llonch, M., Delea, T. E., Richardson, E., Rupnow, M. F. T., Grogg, A. L., & Oster, G. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.75008.x · Cited by 27
MENTAL HEALTH ISSUES WITHIN THE GENERAL HEALTH CARE SYSTEM: IMPLICATIONS FOR THE NURSING PROFESSION
Happell, B., & Platania‐Phung, C. (2005) · Australian journal of advanced nursing · doi:10.37464/2005.223.1974 · Cited by 27
Cost-Effectiveness Analysis of Schizophrenia Relapse Prevention
Bernardo, M., Perea, J. R. A., Rubio-Terr??s, C., & Rejas, J. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626080-00003 · Cited by 27
Prediabetes Assessment and Follow-up in Older Veterans With Schizophrenia
Copeland, L. A., Parchman, M. L., Zeber, J. E., Lawrence, V. A., Downs, J. R., & Miller, A. L. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e56cdc · Cited by 27
Recently evolved human-specific methylated regions are enriched in schizophrenia signals
Banerjee, N., Polushina, T. V., Bettella, F., Giddaluru, S., Steen, V. M., Andreassen, O. A., & Hellard, S. L. (2018) · BMC Evolutionary Biology · doi:10.1186/s12862-018-1177-2 · Cited by 27
Environmental factors and membrane polyunsaturated fatty acids in schizophrenia
Reddy, R. D., & Yao, J. K. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.009 · Cited by 27
Impact of psychotic disorder on transplant eligibility and outcomes
Price, A. C., Whitwell, S., & Henderson, M. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000057 · Cited by 26
Metabolic syndrome in drug naïve schizophrenic patients
Anjum, S., Bathla, M., Panchal, S., Singh, G. P., & Singh, M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.11.006 · Cited by 26
Metadata
- Authors
- Brown, S.
- Affiliations
- Royal South Hants Hospital (GB)
- Corresponding author
- Brown, Steve
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1997-12
- Volume
- 171
- Issue
- 6
- Pages
- 502-508
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2144334285
- Cited by
- 869
- References
- 54
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 15 · 2021: 22 · 2020: 30 · 2019: 22 · 2018: 33 · 2017: 38 · 2016: 37 · 2015: 42 · 2014: 39 · 2013: 45 · 2012: 37
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, excess mortality, suicide, accidental death, natural death, mortality risk factors, confounding variables
- MeSH terms
- Accidents, Cause of Death, Follow-Up Studies, Homicide, Humans, Schizophrenia, Sex Factors, Suicide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review